Early Breast Cancer: HR+/HER2- - New Study Results

(24:2)

Early Breast Cancer: HR-/HER2- - New Study Results

(10:)

Communicating the Risk of Recurrence for Patients With HR+, HER2- Early Breast Cancer

(6:46)

What Can You Do for HER2+? Treatment Methods for Early HER2+ Breast Cancer | Dr Kiley Loh

(3:17)

Ask the expert: Early-stage HER2-positive breast cancer with Adrienne Waks, MD

(1:5:11)

#ESMO21 Expert Video Report on HER2-positive early breast cancer

(8:31)

Know the right treatment for Her2 positive breast cancer I breast cancer stage 1 2 3 and 4

(3:29)

Comprehensive Guide to HER2-Positive Breast Cancer: Stages 1-3 Decoded

(7:26)

Estrogen Receptors \u0026 HER2/neu Receptors in Breast Cancer (a TUTORIAL from Oster Oncology)

(21:19)

HER2-Low Breast Cancer: DESTINY or Good Science?

(11:12)

HER2+ Early-Stage Breast Cancer: Peri-Operative Therapy

(20:25)

Optimizing HER2-Positive Breast Cancer Therapy: Balancing Efficacy and Toxicity

(20:17)

Sharing my Her2+ Breast Cancer Diagnosis Story at 35 years old

(33:34)

Adjuvant Strategies in Early-Stage HER2+ Breast Cancer

(8:26)

Virtual Pink House: Reducing Recurrence Risk of HER2 Positive Breast Cancer

(27:27)

SABCS Snippets: SHR-A1811 in the Neoadjuvant Treatment of HER2-positive Early Breast Cancer

(5:30)

Anthracycline benefit in early HR+/HER2- breast cancer

(47)

The Future of Early HER2-Positive Management

(2:42)

Optimizing treatment in patients with early-stage HER2-positive breast cancer

(4:12)

Decision Factors for Choosing Early HER2-Positive Therapy

(5:42)

EMBER-2: preoperative imlunestrant for ER+/HER2- early stage breast cancer

(51)

Assessment and Followup for Early Stage HR+ HER2- Metastatic Breast Cancer Patients

(3:32)

HER2 Positive Early Stage Breast Cancer - The Breast Cancer Trials Podcast

(7:52)

HER2DX: a new diagnostic tool for early-stage HER2 positive breast cancer

(3:49)

Management of HR-Positive/HER2-Negative Early Breast Cancer: Taking Direction From the Updated Gu...

(34:58)

Conceptualizing Guidelines to Manage Patients with HR–Positive, HER2-Negative Early Breast Cancer

(30:49)

Selecting HER2-Targeted Therapy for Early Breast Cancer

(4:9)

HER2 Positive Breast Cancer: Everything You Must Know

(13:8)

Important considerations in the management of HR+, HER2-negative early breast cancer

(2:5)